Mavyret 100-40 MG tablet 84S
Ended Awarded Last action
- Contract number
- SPE2DR26FJE6U
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,029
Award facts
- Contract value 100% obligated
- $11,028.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,028.50 to AmerisourceBergen Drug Corp for the supply of Mavyret 100-40 mg tablets (84-count units) on December 19, 2025, with an ultimate completion date of December 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceuticals and medical supplies to support military healthcare programs worldwide.
Mavyret is an antiviral medication used in the treatment of hepatitis C, representing the type of specialized pharmaceutical products that AmerisourceBergen supplies through its DLA contracts to support Defense Health Agency operations and other federal healthcare systems. This delivery order exemplifies AmerisourceBergen's role as a critical pharmaceutical distributor within the federal medical supply chain, leveraging its prime vendor status to fulfill federal procurement requirements through open competition. The company's extensive contract portfolio with DLA demonstrates its capability to manage diverse medical product deliveries ranging from routine pharmaceuticals to specialized therapeutics across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FJE6U?
SPE2DR26FJE6U was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26FJE6U worth?
The government has obligated $11,029 on SPE2DR26FJE6U.
Is contract SPE2DR26FJE6U an order under another contract?
Yes. SPE2DR26FJE6U is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJE6U competed?
The extent of competition for SPE2DR26FJE6U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award